valine and Mood Disorders

valine has been researched along with Mood Disorders in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (33.33)29.6817
2010's11 (61.11)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Kremens, DE; McEvoy, JP1
Burke, J; Factor, SA; Hauser, RA; Jimenez, R; Knesevich, MA; Liang, GS; Marder, SR; O'Brien, CF; Ramirez, PM1
George Priya Doss, C; Kajal, K; Magesh, R; Saini, S; Siva, R; Sneha, P; Thirumal Kumar, D1
Burke, J; Correll, CU; Josiassen, RC; Liang, GS; O'Brien, CF1
Burke, J; Josiassen, RC; Kane, JM; Liang, GS; O'Brien, CF1
Burke, J; Calabrese, JR; Farahmand, K; McIntyre, RS; Nierenberg, AA; Siegert, S; Yonan, C1
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; O'Brien, CF; Sajatovic, M; Stacy, M1
Arrigo, R; Bruno, A; Caccamo, D; Currò, M; Gangemi, C; Gugliandolo, A; La Ciura, G; Muscatello, MR; Pandolfo, G; Zoccali, R1
Amouzadeh-Ghadikolai, O; Baranyi, A; Hlade, P; Mangge, H; Meinitzer, A; Reicht, G; Robier, C; Rothenhäusler, HB; Theokas, S; von Lewinski, D1
Feng, X; Jia, J; Wang, W; Xie, Y; Zhang, G1
Burdick, KE; DeRosse, P; Kane, JM; Lencz, T; Lipsky, RH; Malhotra, AK1
Arias-Vásquez, A; Fernández, G; Franke, B; Gerritsen, L; Rijpkema, M; Tendolkar, I; van Oostrom, I1
Bucci, DJ; Davis, FC; Hopkins, ME; Vantieghem, MR; Whalen, PJ1
Hong, CJ; Huo, SJ; Pan, GM; Tsai, SJ; Tung, CL; Yen, FC1
Barr, CL; George, CJ; Kennedy, JL; King, N; Kovacs, M; Ryan, CM; Shaikh, S; Strauss, J1
Enoch, MA; Harris, CR; Hoberman, J; Jiang, X; Lipsky, RH; Marini, AM; Marko, AJ; Tian, F; Waheed, JF; Xu, K1
Jun, TY; Kim, JJ; Lee, C; Pae, CU; Paik, IH; Patkar, A; Yoon, SJ1
Aguilera, M; Delespaul, P; Derom, C; Jacobs, N; Kenis, G; Krabbendam, L; Mengelers, R; Myin-Germeys, I; Peeters, F; van Os, J; Vlietinck, R; Wichers, M1

Trials

5 trial(s) available for valine and Mood Disorders

ArticleYear
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    The American journal of psychiatry, 2017, 05-01, Volume: 174, Issue:5

    Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine

2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
    Psychopharmacology bulletin, 2017, 08-01, Volume: 47, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins

2017
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
    Psychopharmacology bulletin, 2017, 08-01, Volume: 47, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Long Term Adverse Effects; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins

2017
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
    Journal of affective disorders, 2019, 03-01, Volume: 246

    Topics: Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Tardive Dyskinesia; Tetrabenazine; Valine

2019
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:8

    Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Minimal Clinically Important Difference; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine; Vesicular Monoamine Transport Proteins

2019

Other Studies

13 other study(ies) available for valine and Mood Disorders

ArticleYear
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
    The Journal of clinical psychiatry, 2020, Jan-28, Volume: 81, Issue:1

    Topics: Antipsychotic Agents; Diagnosis, Differential; Drug Monitoring; Early Diagnosis; Humans; Membrane Transport Modulators; Mood Disorders; Patient Care; Patient Education as Topic; Psychology; Risk Assessment; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine

2020
Analyzing the Effect of V66M Mutation in BDNF in Causing Mood Disorders: A Computational Approach.
    Advances in protein chemistry and structural biology, 2017, Volume: 108

    Topics: Amino Acid Sequence; Brain-Derived Neurotrophic Factor; Conserved Sequence; Humans; Methionine; Molecular Dynamics Simulation; Mood Disorders; Point Mutation; Protein Interaction Maps; Protein Structure, Secondary; Valine

2017
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders.
    Journal of affective disorders, 2015, May-15, Volume: 177

    Topics: Alleles; Analysis of Variance; Bipolar Disorder; Catechol O-Methyltransferase; Depressive Disorder, Major; Female; Humans; Leucine; Male; Methionine; Middle Aged; Mood Disorders; Mutation, Missense; Polymorphism, Genetic; Valine

2015
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Adult; Amino Acids, Branched-Chain; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Down-Regulation; Energy Metabolism; Female; Humans; Isoleucine; Leucine; Male; Middle Aged; Mood Disorders; Nervous System; TOR Serine-Threonine Kinases; Valine

2016
Clinical characterization of an APP mutation (V717I) in five Han Chinese families with early-onset Alzheimer's disease.
    Journal of the neurological sciences, 2017, Jan-15, Volume: 372

    Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Apolipoprotein E4; Asian People; Cognition Disorders; DNA Mutational Analysis; Family Health; Female; Humans; Isoleucine; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Mutation; Neuropsychological Tests; Valine

2017
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes.
    The British journal of psychiatry : the journal of mental science, 2009, Volume: 194, Issue:4

    Topics: Adult; Alleles; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Genetic Markers; Genotype; Haplotypes; Humans; Male; Mood Disorders; Polymorphism, Genetic; Schizophrenia; Valine

2009
Interaction between BDNF Val66Met and childhood stressful life events is associated to affective memory bias in men but not women.
    Biological psychology, 2012, Volume: 89, Issue:1

    Topics: Adolescent; Adult; Bias; Brain-Derived Neurotrophic Factor; Female; Genetic Association Studies; Genotype; Humans; Life Change Events; Male; Mental Recall; Methionine; Mood Disorders; Polymorphism, Genetic; Psychiatric Status Rating Scales; Sex Factors; Surveys and Questionnaires; Valine; Young Adult

2012
Differential effects of acute and regular physical exercise on cognition and affect.
    Neuroscience, 2012, Jul-26, Volume: 215

    Topics: Activities of Daily Living; Adolescent; Adult; Affect; Brain-Derived Neurotrophic Factor; Cognition; Exercise; Genetic Testing; Humans; Methionine; Mood Disorders; Neuropsychological Tests; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Recognition, Psychology; Stress, Psychological; Valine; Young Adult

2012
Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.
    Neuropsychobiology, 2003, Volume: 48, Issue:4

    Topics: Adult; Age of Onset; Aged; Brain-Derived Neurotrophic Factor; Case-Control Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methionine; Middle Aged; Mood Disorders; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis; Suicide; Valine

2003
BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder.
    Neuromolecular medicine, 2004, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Child; Dopamine; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Intelligence; Male; Memory; Methionine; Mood Disorders; Phenotype; Polymorphism, Genetic; Sex Factors; Valine

2004
BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:7

    Topics: Adult; Amino Acid Substitution; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Cells, Cultured; Diagnostic and Statistical Manual of Mental Disorders; Electrophoretic Mobility Shift Assay; Embryo, Mammalian; Female; Gene Frequency; Genetic Variation; Genotype; Hippocampus; Humans; Male; Methionine; Middle Aged; Mood Disorders; Neurons; Personality Inventory; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Valine

2005
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism and mood disorders: a preliminary study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Sep-30, Volume: 30, Issue:7

    Topics: Adult; Alanine; Chi-Square Distribution; DNA Mutational Analysis; Female; Humans; Male; Middle Aged; Mood Disorders; Polymorphism, Genetic; Superoxide Dismutase; Valine

2006
The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:13

    Topics: Adaptation, Psychological; Adolescent; Adult; Affect; Amino Acid Substitution; Brain; Brain Chemistry; Catechol O-Methyltransferase; Depressive Disorder; Dopamine; Female; Humans; Male; Methionine; Middle Aged; Mood Disorders; Polymorphism, Genetic; Reward; Substance-Related Disorders; Valine; Young Adult

2008